Home
Scholarly Works
607 NCIC CTG IND.196: Phase I Study of Foretinib...
Conference

607 NCIC CTG IND.196: Phase I Study of Foretinib (GSK1363089) and Erlotinib in Patients with Advanced Pretreated NSCLC

Authors

Leighl NB; Tsao MS; Ho C; Shepherd FA; Murray N; Goffin J; Nicholas G; Seymour L; Goss GD; Bradbury P

Volume

48

Publisher

Elsevier

Publication Date

November 1, 2012

DOI

10.1016/s0959-8049(12)72404-8

Conference proceedings

European Journal of Cancer

ISSN

0959-8049

Contact the Experts team